Salesforce, the Customer Success Platform and world’s #1 CRM company, today announced that Eli Lilly and Company—a Fortune 500 company and global leader in healthcare — has expanded its use of the Salesforce Platform to develop more innovative and intuitive apps that are designed to personalize patient support programs, unite care teams and ultimately improve patient outcomes.
Since 1876, Lilly has succeeded in helping people live longer, healthier and more active lives by creating high-quality medicines that meet real patient needs. However, expectations have changed tremendously in recent years, as many patients today want their providers and pharmaceutical companies to connect with them through mobile, social and cloud technologies.
To address evolving patient needs, Lilly turned to Salesforce to help launch more than 50 apps over the last two years. These are internal and external facing apps that Lilly has used to better understand patient insights and engage in a way patients prefer. For example, Lilly TrialGuide helps patients learn about clinical trials, find one that’s right for them and connect with the clinic. With its expanded use of the Salesforce Platform, Lilly is doubling down on its efforts to develop apps that will lead to more relevant and meaningful touch-points along every step of the patient journey.
Comments on the News
“Patient expectations have changed dramatically in the last five years, and developing innovative medicines is no longer enough,” said Rob Brown, senior vice president and chief marketing officer at Lilly. “Today, patients want relevant and easily digestible information they can access when they need it most that will help them better understand and manage their condition. An app can be a great vehicle to help achieve this. With Salesforce, we’re planning for the future, developing technologies and apps that enable us to meet patients at a point of need, rather than at a point of request or requirement — on any device or channel.”
“For the first time in history, healthcare IT is shifting toward the patient, and companies that build strong communities and connections around the medicines they provide will be able to better listen to patient needs and ultimately provide better outcomes,” said Joshua Newman, M.D., chief medical officer, GM, Salesforce Healthcare and Life Sciences. “With Salesforce, Lilly is making an industry leading investment, building new apps to provide proactive support and engage patients in familiar and effective ways. By guiding patients along their treatment journeys, Lilly is truly putting them at the center of their care.”